Varicella-zoster virus immunity and prevention: a conference perspective.
This report offers a concise overview of the VZV Conference, highlighting recent developments in the field and speculating on areas of greatest opportunity and need for future work. The goal of eradicating VZV disease will be facilitated by a multifaceted research agenda directed at a fuller comprehension of how the virus replicates, spreads and persists, and how it eludes host immune responses.
Straus
S E
SE
Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1882, USA.
D000818:Animals; D019433:Chickenpox Vaccine / Q000276:immunology; D004195:Disease Models, Animal; D006562:Herpes Zoster / Q000453:epidemiology / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D014645:Herpesvirus 3, Human / Q000276:immunology* / Q000502:physiology; D006801:Humans; D017735:Virus Latency
D019433:Chickenpox Vaccine